Remove 2015 Remove Portfolio Remove S&P
article thumbnail

Trader of the Year Hedge Fund: Conversant Capital’s David Alfred

The TRADE

I was there through 2015, then Bank of America, before I joined Conversant Capital in early 2021. When Mike called me about the opportunity to join Conversant, he emphasised the firm’s long-term, buy-and-hold strategy, akin to private equity. There’s been a reopening in capital markets. It’s been busy.

Funds 59
article thumbnail

Covid-19 Impact on US Private Capital Raising Activity in 2020

InvestmentBank.com

When the initial wave of uncertainty around COVID-19 set in during March 2020, the debt market flipped on its head, paving a path to the worst debt-raising year since 2015 [6]. Meanwhile, fundraisers suffered a significant reduction in new investments — on pace for the lowest annualized amount since 2015. L., & Jagat, P.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sports Private Equity: Bright Spot in a Troubled PE Landscape or an Emerging Bubble?

Mergers and Inquisitions

This happened for a few reasons: 1) Soaring Valuations – Many sources say that sports team valuations “outperformed” the S&P 500 over the past 20 years, which is a polite way of saying that many teams are now valued at extremely high multiples. When the fans are passionate, there are infinite ways to milk the brand’s value.

article thumbnail

Cooley’s 2023 Tech M&A Year in Review: An AI-Generated Glass Half Full

Cooley M&A

2023’s much-discussed downturn in mergers & acquisitions – with global M&A volume and value down 6% and 17%, respectively, from 2022 – was largely driven by the slowdown in the tech sector, with global tech M&A volumes down 51% year over year, while other sectors saw marked increases. [1] 10] Deal Point Data; Cooley analysis.

M&A 59
article thumbnail

Healthcare 2021: Trends, M&A & Valuations

InvestmentBank.com

Government funded programs include Medicare, Medicaid, Children’s Health Insurance Program, and the Veterans Health Administration. Today, there is a movement towards utilizing molecular diagnostics and personalized medicine making a diverse portfolio of products critical. James VonOsdol & Mitch Morris, 2017 Outlook on U.S.